Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
keywords for AML?
|
malignant disease of the bone marrow in which hematopoietic precursors are arrested in an early stage of development
|
|
incidence of AML?
|
2.5/100'000, rising with increasing age
|
|
what proportion of AML affects adults?
|
80%
|
|
median age in AML?
|
60 years
|
|
principal pathophysiology in AML?
|
maturational arrest of bone marrow cells in earliest stages of development <-- in many cases activation of abnormal genes through chromosomal translocations and other genetic abnormalities
|
|
major disease processes in AML?
|
marked decrease in production of normal blood cells --> anemia, thrombocytopenia, neutropenia
rapid proliferation of arrested cells with accumulation in the bone marrow, blood and frequently liver and spleen |
|
M:F in AML?
|
M>F, likely because MDS more frequent in men and advanced MDS often with progression to AML
|
|
principal groups of clinical symptoms in AML?
|
symptoms from bone marrow failure
and/or symptoms from organic infiltration with leukemic cells |
|
major symptoms of bone marrow failure in AML?
|
anemia, neutropenia, thrombocytopenia -->
fatigue, history of persistent upper respiratory infections and bleeding |
|
most common sites of organic infiltration with leukemic cells in AML?
|
spleen, liver, gums, skin
|
|
organic infiltration most common in which forms of AML?
|
monocytic subtypes
|
|
symptoms from splenomegaly?
|
fullness in LUQ and early satiety
|
|
symptoms from gum infiltration?
|
gingiva hyperplasia, gingivitis, gum bleeding
|
|
symptoms from leukostasis (hyperviscosity syndrome)?
|
triad of bleeding diathesis, visual disturbances and focal neurologic signs
bleeding: epistaxis or gingivorrhagia visual disturbances: decreased visual acuity, distended or thrombotic veins, papillary edema focal neurologic signs: dizziness, seizures, coma, stroke additionally respiratory distress altered mental status and priapism |
|
which of the hematologic disorders is the most ccommon risk factor for AML?
|
presence of antecedent hematologic disorder, most common of which is MDS
others are aplastic anemia, MPN (myelofibrosis, PV) and paroxysmal nocturnal hemoglobinuria |
|
congenital disorders presenting a risk factor for AML?
|
Down syndrome
Bloom syndrome Fanconi anemia neurofibromatosis --> usually AML during childhood |
|
environmental exposures presenting a risk factor for AML?
|
radiation exposure
smoking (OR 1.5) benzene (=Benzol) exposure |
|
major groups of risk factors for AML?
|
previous exposure to chemotherapeutic agents
antecedent hematologic disorder congenital disorders environmental exposures mnemonic: PACE |
|
types of chemotherapy as risk factor for AML?
|
alkylating agents
often MDS then AML topoisomerase-II inhibitors no MDS before AML |
|
criteria for diagnosis of acute leukemia?
|
>20% blasts in the bone marrow
|
|
most common subtype of AML associated with DIC?
|
acute promyelocytic leukemia (APL) = M3
|
|
what are the major WHO classification groups in AML?
|
AML with recurrent genetic abnormalities
AML with myelodysplasia-related changes therapy-related myeloid neoplasms AML, NOS (not otherwise specified) |
|
object of induction therapy?
|
complete hematologic remission
i.e. blasts <5%, "normalisation " of peripheral blood count |
|
common induction therapy in AML exc M3?
|
combination therapy
ara-C plus anthracycline (eg daunorubicin, idarubicin) mnemonic: AML --> American Airlines = AA |
|
object of consolidation therapy in AML?
|
prevention of relapse
|
|
options in consolidation therapy in younger patients in AML?
|
chemotherapy, eg high-dose ara-C
autologous stem-cell transplantation allogeneic stem cell transplantation |
|
what are the classification systems for AML?
|
WHO 2008
FAB |
|
what is the basis of the WHO classification of AML?
|
cytogenetic, molecular and immunphenotype information
|
|
what is the basis of the FAB classification of AML?
|
morphology and histochemistry
|
|
what is the classification of AML according to FAB?
|
M0 acute undifferentiated leukemia
M1 acute myeloblastic leukemia M2 acute myeloblastic leukemia with differentiation M3 acute promyelocytic leukemia (APL) M4 acute myelomonocytic leukemia M5 acute monoblastic leukemia M6 erythroleukemia M7 megakaryoblastic leukemia |
|
what is AML M3 and what are characteristic findings?
|
acute promyelocytic leukemia (APL)
cytogenetic findings are t(15;17) and the fusion gene PML-RAR alpha |
|
what are the most powerful prognostic factors in AML?
|
cytogenetic studies
|
|
of what risk are the majority of AML?
|
intermediate risk with either normal cytogenetics or abnormalities that do no confer strong prognostic significance
|
|
what are cytogenetic finding confering poor prognosis in AML?
|
monosomy 5 or 7 or complex cytogenetics with more that threee separate abnormalities
|
|
what is AML M3 and what are characteristic findings?
|
acute promyelocytic leukemia (APL)
cytogenetic findings are t(15;17)(q22;q12) with the fusion gene PML-RAR alpha mnemonic: Promyelocytic-(A)ML, not so RARe |
|
what are the most powerful prognostic factors in AML?
|
cytogenetic studies
|
|
of what risk are the majority of AML?
|
intermediate risk with either normal cytogenetics or abnormalities that do no confer strong prognostic significance
|
|
what are cytogenetic finding confering poor prognosis in AML?
|
monosomy 5 or 7 or complex cytogenetics with more than three separate abnormalities
|
|
what is the treatment for the AML variant APL?
|
induction therapy with an anthracycline plus all-trans-retinoic acid (ATRA)
|
|
what is the median age in APL?
|
40 years, thus considerably lower median age than other subtypes
|
|
with what finding is bleeding in APL frequently associated
|
DIC
|
|
what is the prognosis in AML for adults <60 years?
|
mnemonic: 80-half-half
80% under age 60 with complete remission with high-dose remission therapy half of those with cure (40%) allogeneic bone marrow transplantation curative in half of cases |
|
what is the prognosis in AML for adults >60 years?
|
50% over age 60 with complete remission
cure rate in only 10% mnemonic: 50 + 10 = 60 |
|
what are the principle therapy steps particular in APL?
|
induction therapy, followed by a consolidation therapy, also called postremission therapy and aditionally a maintenance therapy
|
|
what does the maintenance therapy in APL consist of?
|
6-Mercaptopurin daily
Methotrexat weekly ARTRA intervals every 3 months mnemonic: maintenance therapy with MiXed Martial ARTs = MMA |
|
what is the pathognomonic finding in the blood smear of AML?
|
Auer rods, which is an eosinophilic needle-like inclusion in the cytoplasm of blasts
|
|
what are the phenotypic findings in AML?
|
myeloid antigens such as CD13 or CD33
|
|
what is the method to determine the immunophenotype of the leukemia?
|
flow cytometry
|
|
what are the histochemic findings in AML?
|
peroxidase in myeloid cells and butyrate esterase in monocytic cells
|
|
what is the differential diagnosis to AML?
|
other myeloproliferative disorders, such as CML and myelodysplastic syndrome
|